- Record: found
- Abstract: not found
- Article: not found
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Wui-Jin Koh ,
Nadeem R. Abu-Rustum ,
Sarah Bean ,
Kristin Bradley ,
Susana M. Campos ,
Kathleen R. Cho ,
Hye Sook Chon ,
Christina Chu ,
Rachel Clark ,
David Cohn ,
Marta Ann Crispens ,
Shari Damast ,
Oliver Dorigo ,
Patricia J. Eifel ,
Christine M. Fisher ,
Peter Frederick ,
David K. Gaffney ,
Ernest Han ,
Warner K. Huh ,
John R. Lurain ,
Andrea Mariani ,
David Mutch ,
Christa Nagel ,
Larissa Nekhlyudov ,
Amanda Nickles Fader ,
Steven W. Remmenga ,
R. Kevin Reynolds ,
Todd Tillmanns ,
Stefanie Ueda ,
Emily Wyse ,
Catheryn M. Yashar ,
Nicole R. McMillian ,
Jillian L. Scavone
January 18 2019
January 18 2019
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix.
Most cases of cervical cancer are preventable through human papilloma virus (HPV)
vaccination, routine screening, and treatment of precancerous lesions. However, due
to inadequate screening protocols in many regions of the world, cervical cancer remains
the fourth-most common cancer in women globally. The complete NCCN Guidelines for
Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment
of cervical cancer. This manuscript discusses guiding principles for the workup, staging,
and treatment of early stage and locally advanced cervical cancer, as well as evidence
for these recommendations. For recommendations regarding treatment of recurrent or
metastatic disease, please see the full guidelines on NCCN.org.